Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abbott Laboratories's operating cash flow per share for the
three
months ended in Jun. 2026 was CHF1.14.
Abbott Laboratories's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was CHF4.52.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Abbott Laboratories was 9.70% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 0.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Abbott Laboratories's Operating Cash Flow per Share or its related term are showing as below:
XSWX:ABT'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -30.4 Med: 9.5 Max: 21.8
Current: 0.3
During the past 13 years, Abbott Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 21.80% per year. The lowest was -30.40% per year. And the median was 9.50% per year.
XSWX:ABT's 3-Year OCF Growth Rate is ranked worse than 67.69% of 653
companies
in the Medical Devices & Instruments industry
Industry Median: 12.8
vs XSWX:ABT: 0.30
Abbott Laboratories Operating Cash Flow per Share Related Terms
Abbott Laboratories Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories Operating Cash Flow per Share Chart
XSWX:ABT vs SYK, MDT, BSX: Operating Cash Flow per Share Comparison
For the Medical Devices subindustry, Abbott Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF4.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of CHF4.52 mean?
Abbott Laboratories (XSWX:ABT) has a Operating Cash Flow per Share of CHF4.52 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Abbott Laboratories and its competitors. According to the industry distribution chart, Abbott Laboratories ranks #442 out of 653 companies in the Medical Devices & Instruments industry, placing it in the top 67.7%.
Is Abbott Laboratories' Operating Cash Flow per Share too high?
Abbott Laboratories' current Operating Cash Flow per Share is CHF4.52. Based on the distribution chart, Abbott Laboratories ranks #442 out of 653 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Operating Cash Flow per Share compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #442 out of 653 companies for Operating Cash Flow per Share. This places Abbott Laboratories in the lower half of its industry. The industry median Operating Cash Flow per Share is 12.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.80, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current Operating Cash Flow per Share is CHF4.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Operating Cash Flow per Share of CHF4.52. The stock's GF Value™ is CHF109.21, compared to a current price of CHF83.50 — trading 23.5% below its estimated fair value. The current Operating Cash Flow per Share is CHF4.52. Abbott Laboratories' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Operating Cash Flow per Share is CHF4.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of CHF83.50 is trading 23.5% below its estimated GF Value™ of CHF109.21.
Key valuation signals for XSWX:ABT:
Operating Cash Flow per Share: CHF4.52
GF Value™: CHF109.21 vs. price of CHF83.50 (23.5% below fair value)
No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
78GF Score
Get the complete analysis for XSWX:ABT
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ABT has been successfully added to your 
